The prize is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery.
Prize USD 10 000
The Prize has been established by a generous gift from the Chemical Works of Gedeon Richter, Plc. (Budapest, Hungary) to acknowledge the key role that medicinal chemistry plays toward improving human health. Applicants should be received by NOMINATION only, with just one person needing to serve in that capacity, although a total of five (5) individuals should be listed as referees overall. The package must be submitted electronically and should contain a complete resume, a professional biography of not more than two pages, and a one-page summary of what the individual considers to be their activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry. The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Medicinal Chemistry and Drug Development.
For further information please contact Prof. Janos Fischer, Member of the IUPAC Subcommittee on Drug Discovery and Development, by email at email@example.com
Nomination materials should be uploaded by 15 December 2023 to IUPAC Secretariat via the following form: https://www.cognitoforms.com/IUPAC1/IUPACRichterPrize2024NominationForm
Chair of the Selection Committee, Dr. János Fischer congratulated Professor Michael E. Jung on his much-deserved award. The representative of Richter company, Dr. János Éles, presented the plaque for the 2022 IUPAC-Richter Prize.
The award lecture of Professor Michael E. Jung had the following title: Drug Discovery in Academia: Some Success Stories.